Approval · Notice of Compliance 5544 · 2004
AMEVIVE: Notice of Compliance 5544
Issued October 6, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5544
- Date
- October 6, 2004
- Company
- Biogen Idec Canada Inc
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Selective immunomodulating agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMEVIVE | 02259052 | Cancelled Post Market |
| AMEVIVE | 02258986 | — |